[{"NetIncomeLoss_1_Q3_USD":-16509000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":143880000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.0043,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.0157,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q3_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":363000.0,"AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_0_Q3_USD":45331000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.733,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3_Q3_USD":319000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":46885424.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":46803659.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5219000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15187000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.748,"AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_0_Q3_USD":45588000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":15057000.0,"AssetsCurrent_0_Q3_USD":132837000.0,"Assets_0_Q3_USD":147136000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":56094000.0,"CommonStockSharesIssued_0_Q3_shares":46892552.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-272000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":193000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1288000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1311000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":395000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_1_Q3_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":21016000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3_Q3_USD":126000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q3_USD":66000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":193000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":598663000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-132000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":379000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1970000.0,"PrepaidExpenseCurrent_0_Q3_USD":10254000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":46885424.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":46803659.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-436000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":119895000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":1391000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4175000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21067000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":80711000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":312000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_3_Q3_USD":23148000.0,"OperatingLeaseLiability_0_Q3_USD":3721000.0,"CommonStockValue_0_Q3_USD":47000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_position":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2691000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":75281000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":3496000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-16781000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-70306000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":66000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":10506000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":126000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":131375000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":671000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":10400000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":147000.0,"OtherReceivablesNetCurrent_0_Q3_USD":462000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-4608000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":513000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-272000.0,"ShareBasedCompensation_3_Q3_USD":10770000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2654000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46885424.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q3_USD":12471000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":23148000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-87575000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":46803659.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3305000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-70935000.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_3_Q3_USD":0.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_1_Q3_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":363000.0,"RestrictedCashNoncurrent_0_Q3_USD":408000.0,"CommonStockSharesOutstanding_0_Q3_shares":46892552.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-16641000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-471226000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":10506000.0,"LiabilitiesCurrent_0_Q3_USD":16598000.0,"NetIncomeLoss_3_Q3_USD":-70499000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":731000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PrepaidInsurance_0_Q3_USD":745000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.0035,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1264000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.0035,"ProceedsFromStockOptionsExercised_3_Q3_USD":671000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.726,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.726,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":75689000.0,"AccountsPayableCurrent_0_Q3_USD":6483000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":56976000.0,"IncreaseDecreaseInOtherReceivables_3_Q3_USD":-509000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-28000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":55731000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":182000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":45588000.0,"OperatingIncomeLoss_1_Q3_USD":-17020000.0,"OperatingIncomeLoss_3_Q3_USD":-72905000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":9266000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":22993000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"IncomeTaxesReceivable_0_Q3_USD":1252000.0,"OtherComprehensiveIncomeLossTax_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":454000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":11.11,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":10.7,"InterestReceivableCurrent_0_Q3_USD":365000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OtherComprehensiveIncomeLossTax_1_Q3_USD":0.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":436000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":127847000.0,"ProfitLoss_3_Q3_USD":-70499000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.35,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.51,"OperatingExpenses_1_Q3_USD":26286000.0,"OperatingExpenses_3_Q3_USD":95898000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1030000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3029000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8520000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":147136000.0,"PreferredStockValue_0_Q3_USD":null,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":511000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-21751000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":768000.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]